Skip to main content
Donate
Login
IASLC's 50th Anniversary
IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
About Us
About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Careers
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2023 Highlights
Research & Education
Research & Education
Publications, Resources & Guidelines
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 85 - 96 items out of 278 results
ILCN article
CDX Models Help Bring Personalized Treatment for SCLC a Step Closer
ILCN article
Preconditioning Program Shortens Postsurgical Hospital Stay for People with Lung Cancer
ILCN article
Enhancing Understanding of Testing Applications, Best Practices: A Q&A with Dr. Lynette M. Sholl
ILCN article
In Brief for February 9, 2022
ILCN article
In Brief for February 23, 2022
ILCN article
Management of Recurrences after Stereotactic Ablative Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer
ILCN article
Low-Dose CT, ctDNA May Partner for Lung Cancer Detection
ILCN article
Award Lecture Highlights Tumor Evolution Through Liquid Biopsy
ILCN article
Optimal Pathologic Staging of Lung Cancer Depends on More Than the Pathologist
ILCN article
Quality of Life After VATS and SABR for Early-stage Lung Cancer: The Lilac Study
ILCN article
Panel Explores Emerging Treatments and Sequencing Strategies for Patients with Advanced NSCLCs Driven by Rare Oncogenes
ILCN article
Evidence Supports Adding Biological, Pathological, and Molecular Assessments to the TNM Lung Cancer Staging System
Pagination
First
First page
‹
Previous page
…
4
5
6
7
8
9
10
11
12
…
›
Next page
Last
Last page